Search

Your search keyword '"Kenna KP"' showing total 36 results

Search Constraints

Start Over You searched for: Author "Kenna KP" Remove constraint Author: "Kenna KP"
36 results on '"Kenna KP"'

Search Results

1. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology (vol 53, pg 1636, 2021)

2. Association of Variants in the SPTLC1 Gene with Juvenile Amyotrophic Lateral Sclerosis

3. CHCHD10 variants in amyotrophic lateral sclerosis: where is the evidence?

4. Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways

5. Exome-wide rare variant analysis identifies TUBA4A mutations associated with familial ALS

6. predicTTE: An accessible and optimal tool for time-to-event prediction in neurological diseases.

7. Systematic rare variant analyses identify RAB32 as a susceptibility gene for familial Parkinson's disease.

8. Deep learning modeling of rare noncoding genetic variants in human motor neurons defines CCDC146 as a therapeutic target for ALS.

9. Rare and common genetic determinants of mitochondrial function determine severity but not risk of amyotrophic lateral sclerosis.

10. Multiomic analysis reveals cell-type-specific molecular determinants of COVID-19 severity.

11. Whole-genome sequencing reveals that variants in the Interleukin 18 Receptor Accessory Protein 3'UTR protect against ALS.

12. Unbiased metabolome screen leads to personalized medicine strategy for amyotrophic lateral sclerosis.

13. Genome-wide identification of the genetic basis of amyotrophic lateral sclerosis.

14. Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology.

15. Genome-wide study of DNA methylation shows alterations in metabolic, inflammatory, and cholesterol pathways in ALS.

16. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology.

17. Advances in the genetic classification of amyotrophic lateral sclerosis.

18. Common and rare variant analyses combined with single-cell multiomics reveal cell-type-specific molecular mechanisms of COVID-19 severity.

19. Genetic analysis of ALS cases in the isolated island population of Malta.

21. Rare Variant Burden Analysis within Enhancers Identifies CAV1 as an ALS Risk Gene.

22. ATXN1 repeat expansions confer risk for amyotrophic lateral sclerosis and contribute to TDP-43 mislocalization.

23. The project MinE databrowser: bringing large-scale whole-genome sequencing in ALS to researchers and the public.

24. Association of NIPA1 repeat expansions with amyotrophic lateral sclerosis in a large international cohort.

25. ALS-associated missense and nonsense TBK1 mutations can both cause loss of kinase function.

26. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene.

27. Transcription factor Pebbled/RREB1 regulates injury-induced axon degeneration.

28. Reconsidering the causality of TIA1 mutations in ALS.

29. Mutations in the vesicular trafficking protein annexin A11 are associated with amyotrophic lateral sclerosis.

30. NEK1 variants confer susceptibility to amyotrophic lateral sclerosis.

31. Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis.

32. Homozygosity mapping in an Irish ALS case-control cohort describes local demographic phenomena and points towards potential recessive risk loci.

33. Second-generation Irish genome-wide association study for amyotrophic lateral sclerosis.

34. UBQLN2 mutations are not a frequent cause of amyotrophic lateral sclerosis in Ireland.

35. Delineating the genetic heterogeneity of ALS using targeted high-throughput sequencing.

36. Using reference databases of genetic variation to evaluate the potential pathogenicity of candidate disease variants.

Catalog

Books, media, physical & digital resources